Pseudouridine market was valued at US$ 88 million in 2022 and is anticipated to reach US$ 719.5 million by 2029, witnessing a CAGR of 35.4% - valuates Reports

The global Pseudouridine market was valued at US$ 88 million in 2022 and is anticipated to reach US$ 719.5 million by 2029, witnessing a CAGR of 35.4% during the forecast period 2023-2029.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-23Z8927/Global_Pseudouridine_Market_Insights_and_Forecast_to_2028

Pseudouridine, an isomer of uridine (U), is used as a tumor marker to guide the diagnosis, monitoring and efficacy assessment of malignancies such as lung, breast and liver cancers. Although normal mRNA present in vivo has uridine as one of the four nucleic acid compounds in the sequence, mRNA developed as a therapeutic agent or vaccine is made using a modified nucleic acid (pseudouridine) instead of uridine (and other derivatives). Pseudouridine was originally present in the body as a component, such as tRNA (transfer RNA), which is a type of RNA.
The Pseudouridine industry can be broken down into several segments, Powder, Liquid, etc.
Across the world, the major players cover YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies (Maravai LifeSciences), MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Ulcho Biochemical Ltd (FCAD Group), Wuhan Finetech, etc.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the global market, the core manufacturers of pseudouridine include YAMASA CORPORATION and Biosynth Carbosynth etc, and the top 2 manufacturers account for about 60% of the market share. The market include North America, Europe and Asia Pacific, with a share of 50%, 35% and 15%. Powder accounted for 90%. The product is mainly used in vaccines and scientific research, with a share of 80% and 20%.

This report aims to provide a comprehensive presentation of the global market for Pseudouridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pseudouridine.
The Pseudouridine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pseudouridine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pseudouridine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Segment by Type
Powder
Liquid

Segment by Application
Vaccine
Scientific Research

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-23Z8927/global-pseudouridine

Similar report -

https://reports.valuates.com/market-reports/QYRE-Othe-1D215/global-iot-platforms

https://reports.valuates.com/market-reports/QYRE-Auto-M8/global-transdermal-patch

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

This release was published on openPR.